Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway
Authors
Keywords
Nampt, Nad<sup>+</sup>, Nafld, FK866, Sirt1, AMPKα, Mouse
Journal
Lipids in Health and Disease
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-27
DOI
10.1186/s12944-017-0464-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice
- (2016) Natalie E. de Picciotto et al. AGING CELL
- Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death
- (2016) Xiaonan Wang et al. BRAIN RESEARCH
- Hepatic NAD+deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing
- (2016) Can-Can Zhou et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Natural Course of Non-Alcoholic Fatty Liver Disease
- (2016) Luis Calzadilla Bertot et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transcriptional regulation of hepatic lipogenesis
- (2015) Yuhui Wang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting
- (2014) Qilin Gu et al. HEPATOLOGY
- NAD+metabolism: A therapeutic target for age-related metabolic disease
- (2013) Laurent Mouchiroud et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
- (2013) Yuki Kawano et al. JOURNAL OF GASTROENTEROLOGY
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice
- (2011) Jun Yoshino et al. Cell Metabolism
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
- (2011) Yu Li et al. Cell Metabolism
- Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review
- (2011) Yu-Hung Chang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Ethnicity and nonalcoholic fatty liver disease
- (2011) Kiran Bambha et al. HEPATOLOGY
- Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues
- (2010) Marcella Fulco et al. CELL CYCLE
- Genetic control ofde novolipogenesis: role in diet-induced obesity
- (2010) Maggie S. Strable et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
- (2010) Brad Q. Starley et al. HEPATOLOGY
- SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism
- (2010) Bhaskar Ponugoti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease
- (2010) Tuva B. Dahl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
- (2010) Nathalie C. Leite et al. LIVER INTERNATIONAL
- Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus
- (2010) Hala O. El-Mesallamy et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
- (2009) Carles Cantó et al. NATURE
- Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome? A Cross-Sectional Comparison With Adult Treatment Panel III Criteria in Nonobese Nondiabetic Subjects: Response to Musso et al.
- (2008) S. Sookoian et al. DIABETES CARE
- Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
- (2008) R. Aller et al. DIGESTIVE DISEASES AND SCIENCES
- SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
- (2008) Xiuyun Hou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
- (2008) G MUSSO et al. PROGRESS IN LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search